Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. 1989

L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
Department of Chemical Pathology, St Mary's Hospital Medical School, London, UK.

Gross cystic breast disease is a common condition. Women with apocrine breast cysts may be at higher risk of breast cancer than women with cysts which are lined by flattened epithelium. Apocrine cysts have been shown to be associated with higher intracystic levels of dehydroepiandrosterone sulphate and intracystic sodium to potassium ratios of less than 3. In this study we measured the concentrations of epidermal growth factor, dehydroepiandrosterone and its sulphate in breast cyst fluid. The concentrations of all three analytes were significantly higher in cysts with intracystic Na+/K+ ratios of less than 3 than in cysts with electrolyte ratios of greater than or equal to 3 (P less than 0.001). The higher levels of EGF in cysts with low intracystic electrolyte ratios may provide an explanation of why women with apocrine cysts may be at greater risk of breast cancer. Positive correlations were obtained between concentrations of EGF and DHAS and between EGF and DHA, compatible with the view that intracystic EGF levels may be androgen-modulated. A positive correlation was also obtained between DHA and DHAS concentrations which supports the view that DHA in cyst fluid may be derived from the metabolism of DHAS in the breast cyst wall.

UI MeSH Term Description Entries
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D005348 Fibrocystic Breast Disease A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency. Breast Dysplasia,Fibrocystic Mastopathy,Mammary Dysplasia,Adenosis of Breast,Chronic Cystic Mastitis,Cystic Breast Disease,Cystic Disease of Breast,Fibrocystic Changes of Breast,Fibrocystic Disease of Breast,Microglandular Adenosis,Adenoses, Microglandular,Adenosis, Microglandular,Breast Adenosis,Breast Cystic Disease,Breast Cystic Diseases,Breast Disease, Cystic,Breast Disease, Fibrocystic,Breast Fibrocystic Change,Breast Fibrocystic Changes,Breast Fibrocystic Disease,Cystic Mastitis, Chronic,Disease, Cystic Breast,Disease, Fibrocystic Breast,Dysplasia, Breast,Dysplasia, Mammary,Mastopathy, Fibrocystic,Microglandular Adenoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019314 Dehydroepiandrosterone Sulfate The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. DHEA Sulfate,DHA Sulfate,Dehydroisoandrosterone Sulfate,Prasterone Sulfate,Sulfate, DHA,Sulfate, DHEA,Sulfate, Dehydroepiandrosterone,Sulfate, Dehydroisoandrosterone,Sulfate, Prasterone

Related Publications

L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
August 1989, International journal of cancer,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
October 1982, Tumori,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
January 1989, Anticancer research,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
January 1990, Annals of the New York Academy of Sciences,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
October 1988, Cancer research,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
February 1995, The Journal of clinical endocrinology and metabolism,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
November 1991, British journal of cancer,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
November 1985, European journal of cancer & clinical oncology,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
August 1987, European journal of cancer & clinical oncology,
L C Lai, and M W Ghilchik, and N A Shaikh, and M J Reed, and V H James
June 2002, Ginekologia polska,
Copied contents to your clipboard!